[The current state of staphylococcal resistance to chemotherapeutics]

Arzneimittel-Forschung
|January 1, 1983
PubMed

Insights

This study assessed 62 Staphylococci strains against 21 antibacterial agents. Most strains were susceptible, but narrow-spectrum antibiotics are advised for multi-resistant Staphylococcus strains.

Area of Science:

  • Microbiology
  • Bacteriology
  • Antimicrobial Resistance

Context:

  • Staphylococci are significant human pathogens.
  • Antimicrobial susceptibility testing is crucial for effective treatment.
  • Coagulase and hemolytic activity are key markers for Staphylococci classification.

Purpose:

  • To evaluate the susceptibility of Staphylococci strains to various antibacterial substances.
  • To determine the efficacy of different antimicrobial agents against Staphylococci.
  • To provide guidance on antibiotic selection for Staphylococci infections.

Summary:

  • Sixty-two Staphylococci strains, differentiated by coagulase production and hemolytic activity, were tested against 21 antibacterial agents using agar diffusion and dilution methods.
  • The majority of Staphylococci strains exhibited adequate susceptibility to the tested antibiotics.
  • For managing multi-resistant Staphylococci strains, the use of narrow-spectrum antibiotics is recommended.
  • The antibacterial effect of metronidazole combined with mezlocillin or oxacillin was solely dependent on the penicillin component.

Impact:

  • Informs clinical decisions regarding antibiotic therapy for Staphylococci infections.
  • Highlights the importance of susceptibility testing in the face of evolving antimicrobial resistance.
  • Contributes to understanding the mechanisms of action for antibiotic combinations involving Staphylococci.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...